The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1BRAF(V600E) mutation and the biology of papillary thyroid cancer2008 · 233 citations
2. 2Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma2007 · 394 citations
3. 3Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer2008 · 45 citations
4. 4The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma2005 · 222 citations